CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Compare Generiks, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Compare Generiks, Inc.
60 Davids Drive
Phone: (800) 342-6555p:800 342-6555 Hauppauge, NY  11788  United States Ticker: COGECOGE
This company ceased filing statements with the SEC on 2/7/2001.
This company is no longer actively traded on any major stock exchange.
Business Summary
Compare Generiks, Inc. (CGI) is engaged in the distribution, marketing and sale of dietary supplements and OTC non-prescription pharmaceuticals (OTCs). The Company develops and sells products for its own Energex Plus and Compare Generiks lines, and distributes products in the Max Brand and HeadsUp lines. The Company's products include dietary supplements and OTCs. Each product category contains numerous different dosage sizes and various and unique combinations of ingredients. CGI distributes its products under Company-owned trademarks through direct sales to major wholesalers, particularly those that service convenience stores, drug stores, discount department stores, wholesale clubs, petroleum marketers, hospital gift shops and airport gift shops supported by a sophisticated broker network.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20003/31/2000-Yes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Chief Financial Officer, Director Thomas A.Keith 40 10/31/1995
Director RaveendraNandigam 50 11/2/1998 11/2/1998
Director VirginiaSims 40 11/1/1998 11/1/1998
Director TheresaSpinello 41 12/1/1997 12/1/1997

General Information
Number of Employees: 3 (As of 3/31/2000)
Outstanding Shares: 4,914,845 (As of 11/9/2000)
Shareholders: 124
Stock Exchange: OTC
Federal Tax Id: 113289396
Fax Number: (516) 273-0021


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023